Activist Hedge Funds: Full Guide
Activist Bluebell takes stake in GlaxoSmithKline to push for change at top
After bruising year, GSK approaches consumer split in better health, ET BrandEquity
Activist investor Bluebell is latest to call for 'sleeping' GSK's CEO to quit, 2021-09-23
GlaxoSmithKline Earnings Beat Expectations. The CEO Says Her Plan Is Working. - Barrons
Second hedge fund pushes for change in leadership of GSK, GlaxoSmithKline
GSK rejects three Unilever bids to buy consumer healthcare arm, says unit was fundamentally undervalued - Wikinews, the free news source
New GSK takes flight with strong quarter, forecast boost
Under attack: The rise of the activist investors - and how to respond